Protecting mothers and their infants through screening and comprehensive management of sexually transmitted infections in antenatal care in Zimbabwe (PROMISE): study protocol for an open label individually randomised controlled trial

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • This is a large individually randomised trial powered for each individual outcome of the composite primary outcome that, unlike previous sexually transmitted infection (STI) screening trials in low-resource settings, includes stillbirth alongside preterm birth and low birth weight in its primary composite outcome.

  • The intervention is embedded within routine antenatal care across 14 public sector clinics in a high HIV/STI prevalence urban setting, so trial procedures and findings should be directly relevant to comparable low-resource settings where syndromic management remains the standard of care.

  • Gestational age at birth is ascertained using a validated artificial intelligence-supported ultrasound tool, standardising a key outcome measure across a multi-clinic recruitment network.

  • Because the trial evaluates an antenatal care pathway rather than a drug or device, participants and clinical staff cannot be blinded to allocation, although outcome analyses will be conducted by…
    This post was originally published on https://bmjopen.bmj.com